Investec initiates coverage on KIMS with ₹1,000 buy target
Krishna Institute of Medical Sciences (KIMS) gained after Investec initiated coverage with a “buy” rating and a target price of ₹1,000 per share.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.